Key result
LVAD implantation and heart transplantation increased daily physical activity by 60% and 52% respectively at 3 months (P<0.05), but activity remained unchanged thereafter and below healthy subjects.
Why the study?
Does LVAD implantation or heart transplantation improve physical activity and quality of life in patients with heart failure compared to medical therapy and healthy subjects?
Observational (n=54)
Does LVAD implantation or heart transplantation improve physical activity and quality of life in patients with heart failure compared to medical therapy and healthy subjects?
p-value: p=<0.05
LVAD implantation and heart transplantation improve physical activity and quality of life in the first 3 months post-surgery, but these improvements plateau thereafter and remain significantly lower than those of healthy individuals.
LVAD and HT may improve physical activity and QoL over 12 months; leaves open whether gains exceed medical therapy in advanced HF.
The present study defined the short- and long-term effects of left ventricular assist device (LVAD) implantation and heart transplantation (HT) on physical activity and quality of life (QoL). Forty patients (LVAD, n = 14; HT, n = 12; and heart failure [HF], n = 14) and 14 matched healthy subjects were assessed for physical activity, energy expenditure, and QoL. The LVAD and HT groups were assessed postoperatively at 4 to 6 weeks (baseline) and 3, 6, and 12 months. At baseline, LVAD, HT, and HF patients demonstrated low physical activity, reaching only 15%, 28%, and 51% of that of healthy subjects (1,603 ± 302 vs 3,036 ± 439 vs 5,490 ± 1,058 vs 10,756 ± 568 steps/day, respectively, p <0.01). This was associated with reduced energy expenditure and increased sedentary time (p <0.01). Baseline QoL was not different among LVAD, HT, and HF groups (p = 0.44). LVAD implantation and HT significantly increased daily physical activity by 60% and 52%, respectively, from baseline to 3 months (p <0.05), but the level of activity remained unchanged at 3, 6, and 12 months. The QoL improved from baseline to 3 months in LVAD implantation and HT groups (p <0.01) but remained unchanged afterward. At any time point, HT demonstrated higher activity level than LVAD implantation (p <0.05), and this was associated with better QoL. In contrast, physical activity and QoL decreased at 12 months in patients with HF (p <0.05). In conclusion, patients in LVAD and HT patients demonstrate improved physical activity and QoL within the first 3 months after surgery, but physical activity and QoL remain unchanged afterward and well below that of healthy subjects. Strategies targeting low levels of physical activity should now be explored to improve recovery of these patients.
No takes yet. Share an insight, caveat, or question.
Jakovljević et al. (2014) conducted an observational in Heart failure (n=54). Left ventricular assist device (LVAD) implantation and heart transplantation vs. Heart failure patients and healthy subjects was evaluated on Daily physical activity and quality of life (p=<0.05). LVAD implantation and heart transplantation increased daily physical activity by 60% and 52% respectively at 3 months (P<0.05), but activity remained unchanged thereafter and below healthy subjects.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: